{"id":"https://openalex.org/W7201878677","doi":"https://doi.org/10.1093/jacamr/dlag165","title":"Optimizing intravenous amoxicillin for outpatient parenteral antimicrobial therapy","display_name":"Optimizing intravenous amoxicillin for outpatient parenteral antimicrobial therapy","publication_year":2026,"publication_date":"2026-07-02","ids":{"openalex":"https://openalex.org/W7201878677","doi":"https://doi.org/10.1093/jacamr/dlag165","pmid":"https://pubmed.ncbi.nlm.nih.gov/42564837","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13445613"},"language":"en","primary_location":{"id":"doi:10.1093/jacamr/dlag165","doi":"https://doi.org/10.1093/jacamr/dlag165","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jacamr/dlag165","pdf_url":null,"source":{"id":"https://openalex.org/S4210190703","display_name":"JAC-Antimicrobial Resistance","issn_l":"2632-1823","issn":["2632-1823"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-Antimicrobial Resistance","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1093/jacamr/dlag165","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5099035882","display_name":"Zenaw T Wolie","orcid":"https://orcid.org/0000-0001-8643-0068","observed_orcids":["https://orcid.org/0000-0001-8643-0068"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I916065895","display_name":"Debre Markos University","ror":"https://ror.org/04sbsx707","country_code":"ET","type":"education","lineage":["https://openalex.org/I916065895"]}],"countries":["AU","ET"],"is_corresponding":false,"raw_author_name":"Zenaw T Wolie","raw_affiliation_strings":["Department of Pharmacy, College of Medicine and Health Sciences, Debre Markos University , Debre Markos ,","Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, College of Medicine and Health Sciences, Debre Markos University , Debre Markos ,","institution_ids":["https://openalex.org/I916065895"]},{"raw_affiliation_string":"Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037468542","display_name":"Jason Alexander Roberts","orcid":"https://orcid.org/0000-0001-6218-435X","observed_orcids":["https://orcid.org/0000-0001-6218-435X","https://orcid.org/0000-0003-0268-6723"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I19894307","display_name":"Universit\u00e9 de Montpellier","ror":"https://ror.org/051escj72","country_code":"FR","type":"education","lineage":["https://openalex.org/I19894307"]},{"id":"https://openalex.org/I2799393793","display_name":"Royal Brisbane and Women's Hospital","ror":"https://ror.org/05p52kj31","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I1302211766","https://openalex.org/I2799393793","https://openalex.org/I2801244131"]},{"id":"https://openalex.org/I4405269172","display_name":"Metro North Hospital and Health Service","ror":"https://ror.org/03a0hqz22","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4405269172"]}],"countries":["AU","FR"],"is_corresponding":false,"raw_author_name":"Jason A Roberts","raw_affiliation_strings":["Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women\u2019s Hospital , Brisbane, Queensland ,","Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","Herston Infectious Diseases Institute (HeIDI), Metro North Health , Brisbane, Queensland ,","UR UM 103, University of Montpellier, Division of Anesthesia Critical Care and Emergency and Pain Medicine, Nimes University Hospital , Nimes ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women\u2019s Hospital , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I2799393793"]},{"raw_affiliation_string":"Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"Herston Infectious Diseases Institute (HeIDI), Metro North Health , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I4405269172"]},{"raw_affiliation_string":"UR UM 103, University of Montpellier, Division of Anesthesia Critical Care and Emergency and Pain Medicine, Nimes University Hospital , Nimes ,","institution_ids":["https://openalex.org/I19894307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046635592","display_name":"Steven C. Wallis","orcid":"https://orcid.org/0000-0002-2392-9854","observed_orcids":["https://orcid.org/0000-0002-2392-9854"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Steven C Wallis","raw_affiliation_strings":["Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,"],"raw_orcid":"https://orcid.org/0000-0002-2392-9854","affiliations":[{"raw_affiliation_string":"Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073835619","display_name":"Getnet Mengistu Assefa","orcid":"https://orcid.org/0000-0002-8367-5315","observed_orcids":["https://orcid.org/0000-0002-8367-5315"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]},{"id":"https://openalex.org/I4210114501","display_name":"Wollo University","ror":"https://ror.org/01ktt8y73","country_code":"ET","type":"education","lineage":["https://openalex.org/I4210114501"]}],"countries":["AU","ET"],"is_corresponding":false,"raw_author_name":"Getnet M Assefa","raw_affiliation_strings":["Department of Pharmacy, College of Medicine and Health Sciences, Wollo University , Dessie ,","Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy, College of Medicine and Health Sciences, Wollo University , Dessie ,","institution_ids":["https://openalex.org/I4210114501"]},{"raw_affiliation_string":"Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I165143802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042440849","display_name":"Ronald Andrew Seaton","orcid":"https://orcid.org/0000-0002-2509-0597","observed_orcids":["https://orcid.org/0000-0002-2509-0597"]},"institutions":[{"id":"https://openalex.org/I2800368655","display_name":"British Society for Antimicrobial Chemotherapy","ror":"https://ror.org/04yw9eb05","country_code":"GB","type":"other","lineage":["https://openalex.org/I2800368655"]},{"id":"https://openalex.org/I4210158502","display_name":"Queen Elizabeth University Hospital","ror":"https://ror.org/04y0x0x35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I4210158502"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R Andrew Seaton","raw_affiliation_strings":["Department of Infectious Diseases, Queen Elizabeth University Hospital , Glasgow ,","OPAT Initiative, British Society for Antimicrobial Chemotherapy (BSAC) , Birmingham ,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Queen Elizabeth University Hospital , Glasgow ,","institution_ids":["https://openalex.org/I4210158502"]},{"raw_affiliation_string":"OPAT Initiative, British Society for Antimicrobial Chemotherapy (BSAC) , Birmingham ,","institution_ids":["https://openalex.org/I2800368655"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102908968","display_name":"Mark J. Gilchrist","orcid":"https://orcid.org/0009-0003-0625-3535","observed_orcids":["https://orcid.org/0009-0003-0625-3535","https://orcid.org/0000-0003-4529-0243"]},"institutions":[{"id":"https://openalex.org/I153355300","display_name":"Imperial College Healthcare NHS Trust","ror":"https://ror.org/056ffv270","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300"]},{"id":"https://openalex.org/I2800368655","display_name":"British Society for Antimicrobial Chemotherapy","ror":"https://ror.org/04yw9eb05","country_code":"GB","type":"other","lineage":["https://openalex.org/I2800368655"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mark Gilchrist","raw_affiliation_strings":["Department of Infectious Diseases, Imperial College London , London ,","Department of Pharmacy/Infection, Imperial College Healthcare NHS Trust , London ,","OPAT Initiative, British Society for Antimicrobial Chemotherapy (BSAC) , Birmingham ,"],"raw_orcid":"https://orcid.org/0009-0003-0625-3535","affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, Imperial College London , London ,","institution_ids":["https://openalex.org/I47508984"]},{"raw_affiliation_string":"Department of Pharmacy/Infection, Imperial College Healthcare NHS Trust , London ,","institution_ids":["https://openalex.org/I153355300"]},{"raw_affiliation_string":"OPAT Initiative, British Society for Antimicrobial Chemotherapy (BSAC) , Birmingham ,","institution_ids":["https://openalex.org/I2800368655"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048978890","display_name":"Fekade Bruck Sime","orcid":"https://orcid.org/0000-0003-4061-2063","observed_orcids":["https://orcid.org/0000-0003-4061-2063"]},"institutions":[{"id":"https://openalex.org/I165143802","display_name":"The University of Queensland","ror":"https://ror.org/00rqy9422","country_code":"AU","type":"education","lineage":["https://openalex.org/I165143802"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Fekade B Sime","raw_affiliation_strings":["Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","School of Pharmacy and Pharmaceutical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,"],"raw_orcid":"https://orcid.org/0000-0003-4061-2063","affiliations":[{"raw_affiliation_string":"Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I165143802"]},{"raw_affiliation_string":"School of Pharmacy and Pharmaceutical Sciences, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland , Brisbane, Queensland ,","institution_ids":["https://openalex.org/I165143802"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5048978890"],"corresponding_institution_ids":["https://openalex.org/I165143802"],"apc_list":{"value":1978,"currency":"GBP","value_usd":2609},"apc_paid":{"value":1978,"currency":"GBP","value_usd":2609},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.5740137,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"8","issue":"4","first_page":"dlag165","last_page":"dlag165"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2402","display_name":"Applied Microbiology and Biotechnology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amoxicillin","display_name":"amoxicillin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/outpatient-parenteral-antimicrobial-therapy","display_name":"outpatient parenteral antimicrobial therapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/probenecid","display_name":"probenecid","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.574999988079071},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.6830000281333923},{"id":"https://openalex.org/keywords/time-above-mic","display_name":"time above MIC","score":0.7429999709129333},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.6449999809265137},{"id":"https://openalex.org/keywords/intermittent-infusion","display_name":"intermittent infusion","score":0.7979999780654907},{"id":"https://openalex.org/keywords/prolonged-infusion","display_name":"prolonged infusion","score":0.8830000162124634},{"id":"https://openalex.org/keywords/dose-optimization","display_name":"dose optimization","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C2779708577","wikidata":"https://www.wikidata.org/wiki/Q201928","display_name":"Amoxicillin","level":3,"score":0.8831999897956848},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7565000057220459},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7366999983787537},{"id":"https://openalex.org/C2776769776","wikidata":"https://www.wikidata.org/wiki/Q900898","display_name":"Probenecid","level":2,"score":0.5993000268936157},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5058000087738037},{"id":"https://openalex.org/C3019249092","wikidata":"https://www.wikidata.org/wiki/Q274493","display_name":"Antibacterial agent","level":3,"score":0.4481000006198883},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.4097999930381775},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3853999972343445},{"id":"https://openalex.org/C35785553","wikidata":"https://www.wikidata.org/wiki/Q756720","display_name":"Ambulatory","level":2,"score":0.3610999882221222},{"id":"https://openalex.org/C4937899","wikidata":"https://www.wikidata.org/wiki/Q68541106","display_name":"Antimicrobial","level":2,"score":0.3546000123023987},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32249999046325684},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.3158999979496002},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.30059999227523804},{"id":"https://openalex.org/C2780272996","wikidata":"https://www.wikidata.org/wiki/Q1261151","display_name":"Therapeutic drug monitoring","level":3,"score":0.28290000557899475},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.28279998898506165},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2628999948501587},{"id":"https://openalex.org/C46821324","wikidata":"https://www.wikidata.org/wiki/Q7094540","display_name":"Onset of action","level":2,"score":0.2583000063896179},{"id":"https://openalex.org/C2776205632","wikidata":"https://www.wikidata.org/wiki/Q415709","display_name":"Amoxicillin/clavulanic acid","level":5,"score":0.25760000944137573},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.2522999942302704}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1093/jacamr/dlag165","doi":"https://doi.org/10.1093/jacamr/dlag165","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jacamr/dlag165","pdf_url":null,"source":{"id":"https://openalex.org/S4210190703","display_name":"JAC-Antimicrobial Resistance","issn_l":"2632-1823","issn":["2632-1823"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-Antimicrobial Resistance","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13445613","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13445613/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13445613/pdf/dlag165.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC Antimicrob Resist","raw_type":"Text"},{"id":"pmid:42564837","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42564837","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-antimicrobial resistance","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-05775167v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/hal-05775167","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"JAC-Antimicrobial Resistance, 2026, 8 (4), ⟨10.1093/jacamr/dlag165⟩","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1093/jacamr/dlag165","doi":"https://doi.org/10.1093/jacamr/dlag165","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jacamr/dlag165","pdf_url":null,"source":{"id":"https://openalex.org/S4210190703","display_name":"JAC-Antimicrobial Resistance","issn_l":"2632-1823","issn":["2632-1823"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAC-Antimicrobial Resistance","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[{"id":"https://openalex.org/G368407344","display_name":"Centre of Research Excellence - REduce the burden of antimicrobial reSistance through oPtimal, persONalised Dosing (RESPOND)","funder_award_id":"2007007","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"},{"id":"https://openalex.org/G7554447735","display_name":"Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia","funder_award_id":"1197866","funder_id":"https://openalex.org/F4320334705","funder_display_name":"National Health and Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320320030","display_name":"British Society for Antimicrobial Chemotherapy","ror":"https://ror.org/04yw9eb05"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7201878677.pdf","grobid_xml":"https://content.openalex.org/works/W7201878677.grobid-xml"},"referenced_works_count":33,"referenced_works":["https://openalex.org/W1696888925","https://openalex.org/W2022341655","https://openalex.org/W2030345226","https://openalex.org/W2042002310","https://openalex.org/W2044537173","https://openalex.org/W2045823446","https://openalex.org/W2055484072","https://openalex.org/W2077569069","https://openalex.org/W2114849635","https://openalex.org/W2132628168","https://openalex.org/W2147631440","https://openalex.org/W2291656941","https://openalex.org/W2495444602","https://openalex.org/W2625396968","https://openalex.org/W2888995183","https://openalex.org/W2914477527","https://openalex.org/W2968122707","https://openalex.org/W3022105987","https://openalex.org/W3042302441","https://openalex.org/W3042738614","https://openalex.org/W3214802922","https://openalex.org/W4228998458","https://openalex.org/W4281677276","https://openalex.org/W4283211799","https://openalex.org/W4317830065","https://openalex.org/W4353017232","https://openalex.org/W4385658536","https://openalex.org/W4395053189","https://openalex.org/W4402787579","https://openalex.org/W4403517821","https://openalex.org/W4409510243","https://openalex.org/W4410071161","https://openalex.org/W4410313109"],"related_works":["https://openalex.org/W2132628168","https://openalex.org/W3000351039","https://openalex.org/W2968122707","https://openalex.org/W3175637619","https://openalex.org/W3191518597","https://openalex.org/W1696888925","https://openalex.org/W3088252315","https://openalex.org/W3003162","https://openalex.org/W7169625422","https://openalex.org/W2330464810"],"abstract_inverted_index":{"Background":[0],"and":[1,31,44,58,83,100,122,135,229],"objectives:":[2],"Poor":[3],"aqueous":[4,213],"stability":[5,30,132],"limits":[6],"the":[7,86,110,131,138,149],"use":[8],"of":[9,12,34,133,137,145,154,157,166,193,202,233],"continuous":[10],"infusion":[11,183,231],"intravenous":[13],"(IV)":[14],"amoxicillin":[15,29,37,119,159,195,234],"in":[16,49],"outpatient":[17],"parenteral":[18],"antimicrobial":[19],"therapy.":[20],"This":[21],"study":[22],"aimed":[23],"to":[24,102,108,178,188,236],"evaluate":[25,109],"whether":[26,32],"buffering":[27,127],"improves":[28],"co-administration":[33],"probenecid":[35,146,167,203],"enhances":[36],"exposure.":[38],"Methods:":[39],"Amoxicillin":[40],"solutions":[41],"(4.17,":[42],"50,":[43],"66.6":[45],"mg/mL)":[46],"were":[47],"prepared":[48],"0.3%":[50],"citrate-buffered":[51],"saline":[52],"(pH":[53],"7),":[54],"water":[55],"for":[56,66,116,151,222],"injection,":[57],"0.9%":[59],"w/v":[60],"saline,":[61],"then":[62],"stored":[63],"at":[64,73],"2-8\u00b0C":[65],"10":[67],"days,":[68],"followed":[69],"by":[70,218],"24":[71],"h":[72,198],"32\u00b0C.":[74],"Stability":[75],"was":[76,98,215],"assessed":[77],"using":[78],"a":[79,207],"validated":[80],"assay":[81],"method":[82],"tested":[84,139],"against":[85,173],"UK":[87],"Yellow":[88],"Cover":[89],"Document":[90],"(YCD)":[91],"acceptance":[92],"criteria.":[93,143],"A":[94],"population":[95],"pharmacokinetic":[96],"model":[97],"developed":[99],"used":[101],"perform":[103],"Monte":[104],"Carlo":[105],"dosing":[106],"simulations":[107],"PTA":[111,150,172,209],"(95%":[112],"time":[113],"above":[114],"MIC)":[115],"various":[117],"IV":[118,158,194,225],"regimens,":[120],"with":[121,163,175],"without":[123],"probenecid.":[124],"Results:":[125],"Citrate":[126],"did":[128],"not":[129,216],"improve":[130],"amoxicillin,":[134],"none":[136],"conditions":[140],"met":[141],"YCD":[142],"Co-administration":[144],"significantly":[147],"increased":[148],"amoxicillin.":[152],"Administration":[153],"3-6":[155],"g":[156,165,192,201],"every":[160,196],"12":[161,197],"h,":[162],"1":[164],"once":[168,204],"daily,":[169],"achieved":[170,206],"\u226590%":[171],"pathogens":[174],"MICs":[176,186],"up":[177,187],"4-8":[179],"mg/L":[180],"depending":[181],"on":[182],"durations.":[184],"For":[185],"16":[189],"mg/L,":[190],"4-6":[191],"plus":[199],"2":[200],"daily":[205],"favourable":[208],"(>90%).":[210],"Conclusions:":[211],"Amoxicillin's":[212],"instability":[214],"resolved":[217],"citrate":[219],"buffering.":[220],"However,":[221],"patients":[223],"requiring":[224],"therapy,":[226],"probenecid-boosted":[227],"intermittent":[228],"extended":[230],"regimens":[232],"appear":[235],"be":[237],"promising":[238],"alternatives":[239],"that":[240],"warrant":[241],"further":[242],"clinical":[243],"investigation.":[244]},"counts_by_year":[],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2026-08-08T00:00:00"}